Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergoline derivatives: receptor affinity and selectivity.

S Mantegani1, E Brambilla, M Varasi

  • 1Pharmacia & Upjohn S.p.A., Milan, Italy.

Farmaco (Societa Chimica Italiana : 1989)
|July 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous urinary bladder rupture in a dog with lymphoplasmacytic cystitis.

The Journal of small animal practice·2025
Same author

Retraction Note: p14<sup>ARF</sup> promotes RB accumulation through inhibition of its Tip60-dependent acetylation.

Oncogene·2023
Same author

Microbial contamination of resin composites inside their dispensers: An increased risk of cross-infection?

Journal of dentistry·2021
Same author

Antibacterial and antibiofilm effects of radioactive thermal water.

European review for medical and pharmacological sciences·2021
Same author

Can <i>Pseudomonas aeruginosa</i> growth be modulated by natural compounds?

Journal of biological regulators and homeostatic agents·2021
Same author

Correction to: p14<sup>ARF</sup> inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway.

Oncogene·2021

Ergot alkaloids, derived from Claviceps fungi, offer a wide range of pharmacological effects by interacting with key neurotransmitter receptors. Research has focused on modifying the ergoline structure to develop novel dopaminergic and serotonergic agents.

Area of Science:

  • Natural Products Chemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Ergot alkaloids are indole alkaloids predominantly found in Claviceps fungi species.
  • Ergot, specifically sclerotia of Claviceps purpurea, is recognized for its diverse pharmacological properties.
  • These alkaloids interact with noradrenaline, serotonin, and dopamine receptors, leading to broad biological actions.

Purpose of the Study:

  • To review representative ergoline derivatives and their pharmacological activities.
  • To highlight the significance of ergot alkaloids as a source for drug development.
  • To present research on modifying the ergoline skeleton for novel therapeutic agents.

Main Methods:

  • Literature review of ergoline derivatives and their associated pharmacological data.

Related Experiment Videos

  • Focus on chemical modifications of the ergoline skeleton.
  • Analysis of structure-activity relationships for dopaminergic and serotonergic agents.

    • Main Results:

    • Ergot alkaloids exhibit a wide spectrum of central, neurohumoral, and peripheral effects.
    • The ergoline skeleton serves as a versatile template for developing new drugs.
    • Modification of this structure has led to the identification of novel dopaminergic and serotonergic agents.

    Conclusions:

    • Ergot alkaloids represent a rich source of pharmacologically active compounds.
    • The ergoline scaffold is crucial for developing drugs targeting neurotransmitter systems.
    • Continued research into ergoline derivatives holds promise for future pharmaceutical innovations.